8-KEarnings & ResultsExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Financial Results (Oct 17, 2017)

Filed October 17, 2017For Securities:JNJ

Summary

Johnson & Johnson (JNJ) filed an 8-K on October 17, 2017, reporting its third-quarter financial results for the period ended October 1, 2017. The filing primarily consists of a press release and supplementary financial data. Investors should note that this report serves as an announcement of the company's quarterly performance, detailing sales and earnings figures. While the 8-K itself doesn't contain extensive analytical commentary, the attached exhibits provide the raw data investors need to assess the company's operational and financial condition during the quarter. The key takeaway for investors is to review the provided sales and earnings data in Exhibit 99.15 and 99.20 to understand JNJ's performance relative to expectations and prior periods. These documents are crucial for assessing the company's revenue generation across its various segments and its profitability, which are key indicators of the company's overall health and future prospects. Investors should consult these exhibits for detailed financial metrics.

Key Highlights

  • 1Johnson & Johnson released its third-quarter 2017 sales and earnings results on October 17, 2017.
  • 2The 8-K filing includes a press release (Exhibit 99.15) detailing the quarterly performance.
  • 3Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the third quarter are provided as Exhibit 99.20.
  • 4The filing focuses on reporting financial results, rather than providing forward-looking guidance or strategic commentary.
  • 5Investors can use the attached exhibits to analyze revenue and profit figures for the third quarter ended October 1, 2017.
  • 6This report is a standard disclosure mechanism for quarterly financial performance updates.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide Johnson & Johnson's sales and earnings results for the third quarter of 2017, which ended on October 1, 2017. It serves as a public record of the company's financial performance for that period.

The detailed financial results, including sales data and condensed consolidated statements of earnings for the third quarter, are available in the attached exhibits: Exhibit 99.15 (Press Release) and Exhibit 99.20 (Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings).

This 8-K filing primarily focuses on reporting historical financial results for the third quarter. It does not typically include extensive forward-looking statements, strategic analysis, or future guidance. Investors would need to refer to the press release and supplementary data for the reported numbers and potentially brief commentary within those documents.

The financial data reported in this 8-K filing covers the third quarter of Johnson & Johnson's fiscal year, which ended on October 1, 2017.